Agenus | Nettoeinkommen

Aktienkurs
3.24
Täglich Wechseln
-0.10 -2.99%
Monatlich
12.11%
Jährlich
25.58%
Q1 Prognose
3.23




Nettoeinkommen Veränderung Datum
AbbVie USD 1.82B 1.63B 2025-12
Agenus USD -25.27M 20.59M 2025-03
Amgen USD 1.33B 1.88B 2025-12
AstraZeneca USD 2.33B 207M 2025-12
Bristol-Myers Squibb USD 1.09B 1.11B 2025-12
Celldex Therapeutics USD -81.32M 14.27M 2025-12
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 6.64B 1.05B 2025-12
Gilead Sciences USD 2.18B 869M 2025-12
GlaxoSmithKline GBP 636M 1.38B 2025-12
Glaxosmithkline GBP 2.71B 1.27B 2025-09
Incyte USD 299.28M 124.89M 2025-12
J&J USD 5.12B 36M 2025-12
Jiangsu Hengrui CNY 1.3B 1.27B 2025-09
Karyopharm Therapeutics USD -30.78M 1.29M 2024-12
MacroGenics USD 16.82M 53.07M 2025-09
Merck EUR 902M 250M 2025-09
Merck USD 2.96B 2.82B 2025-12
Northwest Biotherapeutics USD -19.37M 1.5M 2024-09
Novartis USD 3.93B 96M 2025-09
Novavax USD -121.3M 283.68M 2024-09
Pfizer USD -1.65B 5.19B 2025-12
Regeneron Pharmaceuticals USD 844.6M 615.4M 2025-12
Rigel Pharmaceuticals USD 12.42M 13.45M 2024-09
Sangamo BioSciences USD -36.13M 12.96M 2024-06
Veracyte USD 41.15M 22.01M 2025-12


Agenus Nettoeinkommen - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2026.